PH16525A - 9beta,11beta-epoxy-5beta-corticoids - Google Patents

9beta,11beta-epoxy-5beta-corticoids

Info

Publication number
PH16525A
PH16525A PH25134A PH25134A PH16525A PH 16525 A PH16525 A PH 16525A PH 25134 A PH25134 A PH 25134A PH 25134 A PH25134 A PH 25134A PH 16525 A PH16525 A PH 16525A
Authority
PH
Philippines
Prior art keywords
9beta
5beta
11beta
corticoids
epoxy
Prior art date
Application number
PH25134A
Other languages
English (en)
Inventor
Emory Ayer Donald
Carl Alvin Schlagel
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of PH16525A publication Critical patent/PH16525A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J31/00Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J21/00Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0053Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0076Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J51/00Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/004Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa
    • C07J7/0045Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa not substituted in position 16
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/004Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa
    • C07J7/005Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa substituted in position 16
    • C07J7/0055Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • C07J7/0085Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005Oxygen-containing hetero ring
    • C07J71/001Oxiranes
    • C07J71/0015Oxiranes at position 9(11)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
PH25134A 1980-01-31 1981-01-24 9beta,11beta-epoxy-5beta-corticoids PH16525A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/117,401 US4318853A (en) 1980-01-31 1980-01-31 9β,11β-Epoxy-5β-corticoids

Publications (1)

Publication Number Publication Date
PH16525A true PH16525A (en) 1983-11-10

Family

ID=22372732

Family Applications (2)

Application Number Title Priority Date Filing Date
PH25134A PH16525A (en) 1980-01-31 1981-01-24 9beta,11beta-epoxy-5beta-corticoids
PH29092A PH19579A (en) 1980-01-31 1983-06-21 17 - acyloxy-5-b-and 5- -corticoids

Family Applications After (1)

Application Number Title Priority Date Filing Date
PH29092A PH19579A (en) 1980-01-31 1983-06-21 17 - acyloxy-5-b-and 5- -corticoids

Country Status (18)

Country Link
US (1) US4318853A (es)
JP (1) JPS56122398A (es)
KR (1) KR850001208B1 (es)
AU (1) AU538883B2 (es)
BE (1) BE887323A (es)
CA (1) CA1155108A (es)
CH (1) CH644614A5 (es)
DE (1) DE3102397A1 (es)
DK (1) DK39281A (es)
ES (1) ES8300342A1 (es)
FR (1) FR2475048A1 (es)
GB (1) GB2070016B (es)
GR (1) GR73511B (es)
IT (1) IT1193576B (es)
NL (1) NL8100467A (es)
PH (2) PH16525A (es)
SE (1) SE8100563L (es)
ZA (1) ZA8118B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3243482A1 (de) * 1982-11-22 1984-05-24 Schering AG, 1000 Berlin und 4709 Bergkamen Neue 6(alpha)-methylkortikoide, ihre herstellung und verwendung
EP0245357B1 (en) * 1985-10-23 1991-08-07 The Upjohn Company Angiostatic steroids
NL8900507A (nl) * 1989-03-02 1990-10-01 Philips Nv Versterkerschakeling met verzadigingsdetectie.
CA2139549A1 (en) * 1994-01-28 1995-07-29 Kazumi Ogata Corticoid derivatives and pharmaceutical and cosmetic compositions
GB2302807A (en) * 1995-07-04 1997-02-05 Surtech Int Ltd Method and composition for treating atopic eczema
DE19737348C2 (de) 1997-08-27 2002-07-25 Dan-Gabriel Vulpescu Neue Clindamycin und Clotrimazol enthaltende pharmazeutische Zusammensetzung
HUE046243T2 (hu) 2008-05-28 2020-02-28 Reveragen Biopharma Inc Nem-hormonális NF-KB szteroid modulátorok betegség kezelésére
EP2556083A4 (en) 2010-04-05 2013-12-04 Validus Biopharma Inc NONHORMONAL STEROID MODULATORS OF NF-KAPPA-B FOR DISEASE TREATMENT
CN102225959B (zh) * 2011-04-29 2012-11-07 中国科学院上海有机化学研究所 一种16β-甲基-17α-羟基孕甾-3,20-二酮化合物及其合成方法
WO2017004205A1 (en) 2015-06-29 2017-01-05 Reveragen Biopharma, Inc. NON-HORMONAL STEROID MODULATORS OF NF-κB FOR TREATMENT OF DISEASE
US11382922B2 (en) 2019-03-07 2022-07-12 Reveragen Biopharma, Inc. Aqueous oral pharmaceutical suspension compositions

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2831874A (en) * 1954-04-20 1958-04-22 Gnrd Patent Holdings Ltd Improvements in the preparation of 17:21-diacyloxy-2:4-dibromo-3:11:20-triketoallopregnanes
US2854465A (en) * 1955-02-18 1958-09-30 Ciba Pharm Prod Inc Process for the manufacture of halogen-pregnanes and dehalogenation products thereof
DE1195748B (de) * 1961-06-24 1965-07-01 Vismara Francesco Spa Verfahren zur Herstellung von 1'-substituierten 17alpha, 21-(1'-Alkoxy)-methylendioxysterioden
US3681410A (en) * 1970-08-07 1972-08-01 Syntex Corp Process for preparing 17{60 -hydroxy-20-keto and 17{60 ,21-dihydroxy-20-keto pregnanes and derivatives and intermediates thereof

Also Published As

Publication number Publication date
US4318853A (en) 1982-03-09
BE887323A (fr) 1981-07-30
PH19579A (en) 1986-05-26
AU538883B2 (en) 1984-08-30
GB2070016A (en) 1981-09-03
FR2475048A1 (fr) 1981-08-07
JPS56122398A (en) 1981-09-25
ES498938A0 (es) 1982-11-01
GB2070016B (en) 1983-09-14
SE8100563L (sv) 1981-08-01
CA1155108A (en) 1983-10-11
DE3102397A1 (de) 1981-12-24
IT8119360A0 (it) 1981-01-27
AU6651381A (en) 1981-08-06
FR2475048B1 (es) 1984-11-16
NL8100467A (nl) 1981-09-01
IT1193576B (it) 1988-07-08
KR850001208B1 (ko) 1985-08-20
CH644614A5 (de) 1984-08-15
DK39281A (da) 1981-08-01
GR73511B (es) 1984-03-07
ES8300342A1 (es) 1982-11-01
ZA8118B (en) 1982-01-27
KR830005263A (ko) 1983-08-03

Similar Documents

Publication Publication Date Title
CS725784A2 (en) Zpusob vyroby derivatu 4-fenyl-1,3-dioxan-cis-5-ylalkenovych kyselin
CS904383A2 (en) Zpusob vyroby racemickych nebo opticky aktivnich 5-substituovanych oxazolin-2,4-dionu
CS819581A2 (en) Vedeni dulniho dobyvaciho stroje, zejmena uhelneho pluhu
GB2068382B (en) 25-hydroxy-26,26,26,27,27,27-hexafluorocholecalciferol
GB2073752B (en) 2,6-diaminobularines
PH16525A (en) 9beta,11beta-epoxy-5beta-corticoids
GB2075012B (en) 4,1-benzoxazepines
GB2135303B (en) 3,5-dinitrophthalimides
ZA813951B (en) 2,3-bis-hydroxybenzyl-derivatives
ZW6581A1 (en) 2,5-disubstituted-4-pirimidones
NZ197556A (en) 1,1 -alkylenediiminobis(4-( -aminoalkylamino)-anthraquinones
JPS57116050A (en) 2,4-diamino-5-benzylpyrimidine
CS108283A2 (en) Rizeni kloubu ctyrnapravovych kolejovych vozidel, zejmena vozu mestske dopravy
CS673081A2 (en) Cytokininovy, membranove aktivni prostredek
NZ196229A (en) 2-acylpiperidino-4-amino-6,7-dimethoxyquinazolines
GB2086387B (en) 1,8-dihydroxy-9-anthrones
CS582381A1 (en) Osnovni stavek,zejmena stroj pro vyrobu zarovkovych pletenin s plysovymi smyckami
GB2080791B (en) 1,4-benzoxazines
CS70783A1 (en) Hydraulicke drapakove zarizeni, zajistujici spolehlive udrzeni nakladu
CS337581A1 (en) Zasobniky soucasti, zejmena zasobniky nastroju pro kovoobrabeci stroje
GB2086879B (en) 5-aryl-6h-1,3,4-thiadiazine-2-amines
GB8324020D0 (en) Olean-12-ene-3beta,30-substituted compound
ZA81222B (en) 1,3-diformyloxy -2-bromo-2-nitropropane
CS938781A2 (en) Zarizeni pro svirani, zdvihani pechovadel pechovaciho stroje, zejmena pro zhutnovani koksovaneho uhli
JPS56166193A (en) 1,4;3,6-dianhydro-2,5-diazido-2,5-dideoxy- hexitol